Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Retained Earnings
Total
Balance at beginning of period at Dec. 31, 2019 $ 35 $ 6,682 $ 3,348 $ 10,065
Balance at beginning of period (in shares) at Dec. 31, 2019 34,795,313      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation   205   205
Expected tax loss of future stock compensation option exercises   (173)   (173)
Equity component of convertible debt issuance   754   754
Fair value of finders' warrants   32   32
Net loss     (414) (414)
Balance at end of period at Mar. 31, 2020 $ 35 7,500 2,934 10,469
Balance at end of period (in shares) at Mar. 31, 2020 34,795,313      
Balance at beginning of period at Dec. 31, 2020 $ 56 30,841 (11,688) 19,209
Balance at beginning of period (in shares) at Dec. 31, 2020 56,378,939      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation   279   279
Settlement of performance share liability   587   587
Settlement of performance share liability (in shares) 219,838      
Net loss     (1,231) (1,231)
Balance at end of period at Mar. 31, 2021 $ 56 $ 31,707 $ (12,919) $ 18,844
Balance at end of period (in shares) at Mar. 31, 2021 56,598,777